Intravenous busulfan decreases hepatic venoocclusive disease and overall 100-day mortality versus oral busulfan as part of conditioning regimen for autologous and allogeneic stem cell transplantation in children

被引：0
|
作者：
Molina, J. R.
Gonzalez, M.
Verdeguer, A.
Martinez, A.
Badell, I.
Diaz, M. A.
Maldonado, M.
Gonzalez, E.
Munoz, A.
Gomez, P.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S290 / S291
页数：2
相关论文
共 50 条
  • [1] Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality
    Kashyap, A
    Wingard, J
    Cagnoni, P
    Jones, R
    Tarantolo, S
    Hu, W
    Blume, K
    Niland, J
    Palmer, JM
    Vaughan, W
    Fernandez, H
    Champlin, R
    Forman, S
    Andersson, BS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (09) : 493 - 500
  • [2] Intravenous busulfan as part of conditioning regimen in children undergoing allogeneic and autologous haematopoietic stem cell transplantation
    Gomez-Garcia, L.
    Molina, J. R.
    Rodriguez, G.
    Rodriguez-Villa, A.
    Garcia, E.
    Buenasmananas, D.
    Llamas, M. J.
    Chic, C.
    Rojas, R.
    Carmen, M.
    Gomez, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S265 - S265
  • [3] Can we improve toxicity and 100-day overall survival in allogeneic stem cell transplantation?: Once-daily intravenous busulfan versus oral busulfan
    Bermudez, A.
    Yanez, L.
    Colorado, M.
    Insunza, A.
    Iriondo, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S96 - S96
  • [4] Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Mates, M
    Michalska, H
    Hasegawa, W
    Kiss, T
    Daly, A
    Loach, D
    Messner, H
    Lipton, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 36 - 36
  • [5] No differences in terms of toxicity and clinical outcome of intravenous busulfan versus oral busulfan as part of conditioning regimen for autologous and allogeneic stem cell transplantation in children: an analysis of the AIEOP-BMT Registry
    Prete, A.
    Rondelli, R.
    Luksch, R.
    Fagioli, F.
    Ripaldi, M.
    Favre, C.
    Di Bartolomeo, E.
    Lanino, E.
    Ziino, O.
    Zecca, M.
    Messina, C.
    Rovelli, A.
    Caselli, D.
    Pession, A.
    Locatelli, F.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S135 - S135
  • [6] Matched pair analysis comparing intravenous busulfan and oral busulfan as part of conditioning regimen in autologous stem cell transplantation in high risk neuroblastoma
    Prete, A.
    Rondelli, R.
    Fagioli, F.
    Luksch, R.
    Morello, W.
    Pession, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Matched pair analysis comparing intravenous busulfan and oral busulfan as part of conditioning regimen in autologous stem cell transplantation in high-risk neuroblastoma
    Prete, A.
    Rondelli, R.
    Luksch, R.
    Fagioli, F.
    Morello, W.
    Castellini, C.
    Pession, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S292 - S292
  • [8] Clinical results of autologous or allogeneic stem cell transplantation following a new intravenous busulfan dosing as part of conditioning regimen in children: clinical outcomes, toxicity and compliance
    Prete, A.
    Rondelli, R.
    Fagioli, F.
    Luksch, R.
    Morello, W.
    Castellini, C.
    Pession, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S291 - S292
  • [9] Cost-assessment of conditioning regimen in allogeneic haematopoietic stem cell transplantation using IV busulfan (Busilvex) versus oral busulfan:: a French model
    Esperou, H
    Myon, E
    Robin, M
    Chadelat, C
    Ferry, C
    Devergie, A
    Ribaud, P
    Rocha, V
    Socié, G
    Gluckman, E
    BONE MARROW TRANSPLANTATION, 2005, 35 : S224 - S224
  • [10] Regimen related toxicity after thiotepa, cyclophosphamide and intravenous busulfan as conditioning for allogeneic stem cell transplantation
    Sanz, J
    Sanz, GF
    Moscardó, F
    Cupelli, L
    Montesinos, P
    Puig, N
    Lorenzo, I
    Benlloch, L
    Jarque, I
    de la Rubia, J
    Martínez, J
    Martín, G
    Sanz, MA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 33 - 34
12345